Flumazenil Injection, USP

Pfizer Inc

Revision date : 2011-11-18

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

25322-68-3

Name of the chemical

polyethyleneglycol

Concentration

N/A

EC/CAS

200-580-7/64-19-7

Name of the chemical

acetic acid

Concentration

N/A

EC/CAS

215-185-5/1310-73-2

Name of the chemical

sodium hydroxide

Concentration

N/A

EC/CAS

231-595-7/7647-01-0

Name of the chemical

Hydrochloric acid

Concentration

N/A

EC/CAS

202-785-7/99-76-3

Name of the chemical

4-hydroxybenzoic acid, methyl ester

Concentration

N/A

EC/CAS

202-307-7/94-13-3

Name of the chemical

Propylparaben; propyl 4-hydroxybenzoate

Concentration

N/A

EC/CAS

231-791-2/7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

General Information

Version

2.0

Revision date

2011-11-18

Product name

Flumazenil Injection, USP

Product name

Flumazenil Injection, USP

Identification on the label/Trade name

Not applicable

Chemical name

Benzodiazepine receptor antagonist

1.2.1 Relevant identified uses

Pharmaceutical product used as anti-sedation agent

Emergency telephone

1-800-424-9300, +1-703-527-3887

Icons in SDS

M004 M009 M010 M011 M017

Company Information

company name

Pfizer Inc

e-mail address of the competent person responsible for the Safety Data Sheet

pfizer-MSDS@pfizer.com

Section 2

SECTION 2: Hazards identification

Appearance Liquid solution

Hazard statements

Non-hazardous in accordance with international standards for workplace safety.

Additional information

Short Term May cause irritation (based on components) . Long Term Repeat-dose studies in animals have shown a potential to cause adverse effects on developing fetus. Known Clinical Effects Adverse effects associated with therapeutic use include seizure, dizziness, increased sweating, headache, blurred vision. Australian Hazard Classification (NOHSC): Note Non-Hazardous Substance. Non-Dangerous Goods. This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.